 |
12 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- | albuterol inhalational powder (A006 DPI) / Amphastar
Trial completion, Enrollment change: Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers (clinicaltrials.gov) - Apr 7, 2015
P2, N=22, Completed, Sponsor: Amphastar Pharmaceuticals, Inc.
Active, not recruiting --> Completed | N=18 --> 22
- | albuterol inhalational powder (A006 DPI) / Amphastar
Trial completion: Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation (clinicaltrials.gov) - Oct 22, 2014
P2, N=22, Completed, Sponsor: Amphastar Pharmaceuticals, Inc.
Active, not recruiting --> Completed | N=18 --> 22 Recruiting --> Completed
- | albuterol inhalational powder (A006 DPI) / Amphastar
New P2 trial: Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers (clinicaltrials.gov) - Oct 22, 2014
P2, N=18, Active, not recruiting, Sponsor: Amphastar Pharmaceuticals, Inc.
- | albuterol inhalational powder (A006 DPI) / Amphastar
New P2 trial: Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation (clinicaltrials.gov) - Aug 7, 2014
P2, N=24, Recruiting, Sponsor: Amphastar Pharmaceuticals, Inc.
- | albuterol inhalational powder (A006 DPI) / Amphastar
Trial completion: Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation (clinicaltrials.gov) - Jul 8, 2013
P2, N=28, Completed, Sponsor: Amphastar Pharmaceuticals, Inc.
Recruiting --> Completed Recruiting --> Completed
- | albuterol inhalational powder (A006 DPI) / Amphastar
New P2 trial: Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation (clinicaltrials.gov) - Apr 18, 2012
P2, N=28, Completed, Sponsor: Amphastar Pharmaceuticals, Inc.